Form 4 for BDSX BIODESIX INC

Accepted 2022-04-11 00:00:00 ET · period of report 2022-04-07 · accession 0001567619-22-008353 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
I	2022-04-11	2022-04-07	BDSX	Strobeck Matthew	Dir	P - Purchase	$1.79	+558.7K	769.9K	+265%	+$1000.0K
	2022-04-11	2022-04-07	BDSX	Strobeck Matthew	Dir	P - Purchase	$1.79	+558.7K	1.55M	+57%	+$1000.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-04-07	P	A	558,659	$1.79	769,859	I	—	—	(F1) The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
2	Common	Common Stock	2022-04-07	P	A	558,659	$1.79	1,545,586	D By Birchview Fund LLC	—	—	(F1) The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.